Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology provides in vitro diagnostics (IVD) products across the European Union, Asia Pacific, North America, South America, and other international markets. Its offerings include lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions, as well as SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. The company serves the over-the-counter, point-of-care testing, and laboratory markets. Incorporated in 2021, Anbio Biotechnology is based in Frankfurt am Main, Germany.